InfuSystem Holdings, Inc. has announced that it will disclose its financial results for the third quarter of 2026 on November 3, 2026. This is an important event for the company as it prepares to inform investors about its performance during the quarter.

The announcement was made in a filing with the Securities and Exchange Commission on October 27, 2026. The company will also hold a conference call on the same day at 9:00 a.m. Eastern Time to discuss its financial results.

InfuSystem Holdings, Inc. operates in the Surgical & Medical Instruments & Apparatus sector, providing healthcare services related to durable medical equipment. The company aims to facilitate outpatient care for manufacturers and healthcare providers.

According to the filing, the press release detailing the financial results is included as an exhibit to the SEC filing. The information shared during the upcoming conference call could impact investors' perceptions and decisions regarding the company.

The filing does not specify what actions will follow the earnings announcement.

InfuSystem Holdings, Inc. is headquartered at 3851 West Hamlin Road, Rochester Hills, Michigan, and operates under the ticker symbol INFU on the NYSE American exchange. The company is structured into two primary platforms: Patient Services and Device Solutions. The Patient Services segment focuses on providing last-mile solutions for outpatient care involving durable medical equipment, while the Device Solutions segment supports the former by offering direct payer rentals and biomedical services.

The upcoming financial results will cover the third quarter of 2026, and the press release announcing this event is included as Exhibit 99.1 in the SEC filing. The conference call will provide an opportunity for investors to engage directly with the company's management team, which includes Chief Financial Officer Barry Steele, who is available for inquiries.

The filing also notes that the information disclosed in this report is not intended to be filed under the Securities Exchange Act of 1934, thus limiting its liability under that section. This distinction is important for investors to understand the nature of the information being shared.

As of the date of the filing, there are no additional details provided regarding the specific financial metrics or performance indicators that will be discussed during the earnings call.